INOmax (nitric oxide): Difficulties in closing the cylinder valves after use: precautions for use when disconnecting the cylinders from pressure regulators

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
INOmax
Active substance
Nitric oxide
Therapeutic area (MeSH)
  • Hypertension, Pulmonary
  • Respiratory Insufficiency
Procedure number
EMEA/H/C/000337
Regulatory outcome
Maintenance
DHPC type
Quality defect
Human ATC code
R07AX
Dissemination date
03/06/2021

How useful was this page?

Add your rating